Back

Decreased endothelial nitric oxide production in acute decompensated heart failure with reduced ejection fraction

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Pathophysiological determinants and prognostic insights in heart failure with reduced ejection fraction Heart Failure with Reduced Ejection Fraction (HFrEF) HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Roman Falls

RMIT University, Melbourne (Australia)

5 More presentations in this session

Presentation thumbnail
A vascular health triad in acute heart failure with reduced ejection fraction: endothelial dysfunction, oxidative stress and inflammation
Doctor R. Falls (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Impact of age on CPET parameters in patients with heart failure and reduced ejection fraction: implications for advanced therapies
Doctor S. Vila-Sanjuan (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Long-term survival and precisions phenotyping in patients with dilated cardiomyopathy
Doctor M. Wideqvist (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Impact of social, educational and ethnic determinants in guideline-directed medical therapy implementation during heart failure hospitalization
Professor D. D'Amario (Novara, IT)
Abstract Slides Video
Presentation thumbnail
Expression profile of lncRNAs in heart failure as search for a molecular therapy: role of aerobic exercise training
Mr B. Pelozin (Sao Paulo, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Pathophysiological determinants and prognostic insights in heart failure with reduced ejection fraction

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
A vascular health triad in acute heart failure with reduced ejection fraction: endothelial dysfunction, oxidative stress and inflammation
thumbnail
Congress Presentation
Dietary nitrate enhances cardiac function in HFrEF by improving hemodynamics, ameliorating remodeling and resolving inflammation
thumbnail
Congress Presentation
Endothelial dysfunction in HFrEF: investigating the role of red blood cells and guideline directed medical therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources